Silver-Copper-Cadmium-Zinc Brazing Alloys
Lucas-Milhaupt, Inc. Handy & Harman Fairfield
5656 S. Pennsylvania Ave. 1770 Kings Highway
Supplier Emergency Contacts & Phone Number
------------------------------------------
Handy & Harman Fairfield: (203) 259-8321
Lucas-Milhaupt, Inc. Handy & Harman Fairfield
5656 S. Pennsylvania Ave. 1770 Kings Highway
Manufacturer Emergency Contacts & Phone Number
----------------------------------------------
Handy & Harman Fairfield: (203) 259-8321
Product Name: Silver-Copper-Cadmium-Zinc Brazing Alloys
The information in this MSDS is applicable to the products with the following
codes: 21-846, Easy-Flo (31-500), Easy-Flo 25 (31-250), Easy-Flo 25HC (31-257),
Easy-Flo 30 (31-300), Easy-Flo 35 (31-350), Easy-Flo 40 (31-400) (formerly Alloy
32-405), Easy-Flo 45 (31-450), Braze 200 (32-200), and Trimet 177 (38-177).
WARNING: These products contain a chemical(s) known to the State of California
tocause cancer and birth defects or other reproductive harm.
2. Composition/Information On Ingredients
-----------------------------------------
Eye contact with these products in finely-divided forms may cause irritation,
conjunctivitis, ulceration of the cornea, and/or argyria, a permanent blue-gray
discoloration of the eyes, skin, mucous membranes, and respiratory tract.
Skin contact with these products, particularly in finely-divided forms, may
cause irritation, argyria, discoloration, and/or contact dermatitis.
Ingestion of these products in finely-divided forms may cause nausea,
vomiting,and gastrointestinal irritation. Long-term chronic ingestion may
damage the liver, kidneys, gastrointestinal system, and nervous system.
Inhalation of the components of these products is not known to present a
significant risk to health when used according to instructions and with
appropriate protective measures (see Section #8). Inhalation of component
elements has been reported to cause one or more of the following symptoms and
effects upon excessively high or prolonged exposure:
CADMIUM: Acute exposure to cadmium may cause pneumonitis, bronchitis, and
pulmonary edema. Chronic exposure may cause gastrointestinal symptoms, anemia,
rhinitis, discoloration of teeth, kidney disease, microfractures, and cancer.
COPPER: Acute exposure may cause respiratory tractirritation, fever, muscle
ache, chills, cough, weakness, and a metallic taste.Chronic exposure may damage
the liver, kidney, spleen, pancreas, and brain.
SILVER: Chronic exposure via inhalation may cause argyria.
ZINC: Acute exposure to zinc oxide may cause respiratory tract irritation and
"metal fume fever", which is characterized by a metallic taste, cough, dry
throat, chills, fever, tightness of chest, headache, nausea, shortness of
Flush affected areas with water for at least fifteen minutes. Seek medical
Remove contaminated clothing. Wash affected area with large quantities of water
for at least five minutes. Seek medical attention if necessary. Launder or
If subject is conscious, induce vomiting. If unconscious or convulsive, seek
If signs and symptoms of toxicity are observed, remove subject from area,
administer oxygen, and seek medical attention. Keep the subject warm and at
rest. Perform artificial respiration if breathing has stopped.
None of the components are acutely toxic by ingestion, nor are they absorbed
through the skin. Extensive or prolonged skin contact may cause dermatitis
and/orargyria. Inhalation of cadmium fume may cause severe respiratory illness.
In finely-divided form, these products may ignite when exposed to flame or by
reaction with incompatible materials (see Section #10). If present in a fire or
explosion, they may emit fumes of the constituent metals or metal oxides.
If fighting a fire in which these products are present, wear a self-contained
breathing apparatus with full facepiece operated in pressure-demand or other
If a finely-divided form of product is spilled, clean up spillage so as to
minimize dispersion of dust. Wet sweeping or vacuuming using HEPA filtration
No special handling precautions are required.
Do not store in proximity to incompatible materials (see Section #10).
To minimize ingestion, wash hands and face before eating, drinking, applying
8. Exposure Controls/Personal Protection
----------------------------------------
Use appropriate ventilation (e.g., dilution, local exhaust) adequate to maintain
concentrations of all components to within their respective OSHA PELs or
Wear eye protection adequate to prevent eye contact with finely-divided forms of
product and eye injury from the hazards of brazing. Plastic-frame spectacles
with side shields and filter lenses (shade #3 or #4) are recommended.
Wear appropriate protective gloves and clothing to prevent skin injuries from
the hazards of brazing and/or for prolonged or repeated contact with finely-
divided forms of product. Avoid flammable fabrics.
If an exposure level exceeds an applicable exposure standard, use a NIOSH-
approved respirator having a configuration (type of facepiece, filter media,
assigned protection factor, etc.) appropriate to the concentration of the
contaminant(s) generated. For guidance on selection and use of respiratory
protection, consult American National Standard Z88.2 (ANSI, New York, NY 10036
ACGIH TLVs: 0.01 mg/m3 TWA; 0.002 mg/m3 TWA (respirable fraction)
OSHA PELs: 0.1 mg/m3 TWA (fume); 1 mg/m3 (dusts and mists)
ACGIH TLVs: 0.2 mg/m3 TWA (fume); 1 mg/m3 TWA (dusts and mists)
OSHA PEL: 0.01 mg/m3 TWA ACGIH TLV: 0.1 mg/m3 TWA (metal)
ACGIH TLVs: 5 mg/m3 TWA; 10 mg/m3 STEL (as ZnO fume)
Odorless silver-white metals in the form of wire, rod, sheet, powder, tape,
grain, clad alloys, or preformed shapes.
Melting Point: 1110-1170 °F 600-630 °C
Hazardous Polymerization: will not occur
Silver and copper can form unstable acetylides if in contact with acetylene gas.
Ammonia; azides; nitric acid; ethylene imine; chlorine trifluoride; sulfuric
acid; inorganic and organic peroxides; peroxyformic acid; oxalic acid; tartaric
acid; 1-bromo-2-propyne; permonosulfuric acid; ammonium nitrate; hydrazoic acid;
chlorates, barium dioxide; carbon disulfide; halogens; hydroxylamine; hydrazine
mononitrate; manganese chloride; performic acid; tellurium.
Heating to elevated temperatures may liberate metal/metal oxide fumes.
Cadmium is classified as a potential human carcinogen by IARC (Group 1) and
NTP(Group R). It is also regulated as a carcinogen by OSHA. No other
components of this product are classified as potential or demonstrated human
In experimental studies, cadmium has been found to cause reproductive
abnormalities, including reduced birth weights, reduced viability, and
behavioral alterations, among offspring of female rodents. Male rodents exposed
to cadmium have been found to have testicular damage, reduction in sperm counts,
Cadmium has produced mutagenic effects on mammalian cell cultures.
Pre-existing pulmonary diseases (e.g., bronchitis, asthma) may be aggravated by
inhalation exposure, particularly as fume. Chronic exposure by inhalation and/or
ingestion may aggravate pre-existing diseases of the liver, kidneys,
gastrointestinal system, musculoskeletal system, and nervous system.
LD50: 2,330 mg/kg (oral/rat) LC50: 25mg/m3/30min (inhalation/rat)
LD50: 3.5 mg/kg (intraperitoneal/mouse) LC50: No data available
LD50: >5 gm/kg (oral/guinea pig) LC50: No data available
LD50: No data available LC50: No data available
In their intended manner of use, these products should not be released into the
environment, and adverse effects on ecosystems are not anticipated under
recommended conditions of use, storage, and disposal.
Dispose of unused or unusable product in accordance with applicable Federal,
State/Provincial, and local regulations.
These products are not Hazardous Substances or Dangerous Goods per
Acute Health Hazard; Chronic Health Hazard
Ingredient(s) - U.S. Regulatory Information
-------------------------------------------
SARA Title III - Section 313 Form "R"/TRI Reportable Chemical
SARA Title III - Section 313 Form "R"/TRI Reportable Chemical
SARA Title III - Section 313 Form "R"/TRI Reportable Chemical
WHMIS Class(es) and Division(s): D1A, D2A
Components on Ingredients DisclosureList:
This MSDS Superceeds A Previous MSDS Dated: 07/20/2001
Although reasonable care has been taken in the preparation of this document,
weextend no warranties and make no representations as to the accuracy or
completeness of the information contained therein, and assume no responsibility
regarding the suitability of this information for the user's intended purposes
or for the consequences of its use. Each individual should make a determination
as to the suitability of the information for their particular purpose(s).
Lucas-Milhaupt, Inc. Handy & Harman Fairfield
INFORMATIONSBRIEF Arbeitssicherheit, Forschung und Entwicklung, Gesundheitsschutz, Managementsysteme, Strategieberatung, Software uve • Informationsbrief Dritte Ausgabe Juli 2009 Gesundheitswissenschaftler vermuten jedoch durch Urlauber und ungünstige Witterungsbedin-die Schweinegrippe oder auch neue Influenza gungen einen starken Anstieg der Erkrankungsfäl-greift nun
The Efficacy of Paxil (Paroxetine) for Panic Disorder Journal : The Current Practice of Medicine Authors : Dr Sean D. Hood, Dr Spilios Argyropoulos, Prof David J. Nutt Corresponding Author : Sean Hood ([email protected]) Introduction Substantial advances into the pharmacological treatment of Panic Disorder (PD) have been made in the lasttwo decades. Although tricyclic antidepres